Madrigal Pharmaceuticals (MDGL) Debt Ratio (2022 - 2025)
Historic Debt Ratio for Madrigal Pharmaceuticals (MDGL) over the last 10 years, with Q3 2025 value amounting to 0.25.
- Madrigal Pharmaceuticals' Debt Ratio rose 12858.03% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year increase of 12858.03%. This contributed to the annual value of 0.11 for FY2024, which is 3743.0% down from last year.
- Latest data reveals that Madrigal Pharmaceuticals reported Debt Ratio of 0.25 as of Q3 2025, which was up 12858.03% from 0.12 recorded in Q2 2025.
- In the past 5 years, Madrigal Pharmaceuticals' Debt Ratio registered a high of 0.48 during Q3 2023, and its lowest value of 0.11 during Q2 2024.
- In the last 4 years, Madrigal Pharmaceuticals' Debt Ratio had a median value of 0.16 in 2022 and averaged 0.2.
- In the last 5 years, Madrigal Pharmaceuticals' Debt Ratio crashed by 7737.19% in 2024 and then skyrocketed by 12858.03% in 2025.
- Madrigal Pharmaceuticals' Debt Ratio (Quarter) stood at 0.14 in 2022, then skyrocketed by 32.62% to 0.18 in 2023, then plummeted by 37.43% to 0.11 in 2024, then skyrocketed by 121.06% to 0.25 in 2025.
- Its last three reported values are 0.25 in Q3 2025, 0.12 for Q2 2025, and 0.12 during Q1 2025.